
1. General Information
Laviat 25 mg Capsule is an oral oncology medicine containing Lenalidomide 25 mg. It belongs to the class of immunomodulatory agents and is used in the management of selected blood cancers and bone-marrow disorders.
For international pharmaceutical enquiries, Phoenix Exim, Nagpur, India, can be described as a medicine/pharmaceutical exporter serving markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to destination-country regulations and prescription/import requirements.
2. Product Information
- Brand: Laviat 25 mg Capsule
- Active ingredient: Lenalidomide
- Strength: 25 mg
- Dosage form: Capsule
- Route: Oral
- Manufacturer/Marketer: Zydus Cadila / Zydus Lifesciences
- Typical pack: 10 capsules
- Therapeutic category: Immunomodulator / anti-neoplastic medicine
- Prescription status: Prescription medicine
3. Uses of Laviat 25 mg Capsule
Laviat 25 mg may be prescribed for certain types of:
- Multiple myeloma
- Myelodysplastic syndromes (MDS)
- Deletion 5q MDS
- Mantle cell lymphoma
- Follicular lymphoma
The exact indication and treatment combination depend on the patient's diagnosis and the prescribing specialist.
4. Benefits of Laviat 25 mg Capsule
Lenalidomide can provide therapeutic benefits by:
- Helping control the growth of abnormal blood and cancer cells.
- Modulating the body's immune response against abnormal cells.
- Inhibiting mechanisms that support tumour growth and blood-vessel formation.
- Helping manage certain bone-marrow disorders and associated abnormal blood-cell production.
- Being used as part of combination treatment for multiple myeloma and certain lymphomas.
The benefits vary according to the disease, treatment regimen and individual patient.
5. Side Effects of Laviat 25 mg Capsule
Possible side effects include:
- Fatigue or weakness
- Headache
- Dizziness
- Nausea
- Diarrhea or constipation
- Muscle cramps
- Rash or itching
- Shortness of breath
- Reduced appetite
- Joint, muscle, bone or back pain
- Reduced white blood-cell count
- Reduced platelet count
- Increased susceptibility to infections
Serious complications such as blood clots, severe reduction in blood-cell counts, serious skin reactions and liver problems can occur and require medical attention.
6. Common Side Effects
Some commonly reported side effects include:
- Fatigue
- Headache
- Nausea
- Constipation
- Diarrhea
- Dizziness
- Muscle cramps
- Rash
- Weakness
- Shortness of breath
- Upper respiratory infections
- Reduced blood-cell counts
If side effects are persistent or severe, the treating physician should be contacted.
7. How to Use Laviat 25 mg Capsule
Take Laviat 25 mg exactly according to the oncologist's prescription.
- It may generally be taken with or without food.
- Take it at approximately the same time on scheduled treatment days.
- Swallow the capsule whole with water.
- Do not crush, chew or open the capsule.
- Do not change the dose or treatment schedule without medical advice.
- Regular blood tests may be required during treatment.
Because lenalidomide dosing can depend on the cancer being treated, kidney function and the overall treatment regimen, the dose should not be self-selected.
8. How Laviat 25 mg Works
Laviat contains lenalidomide, which modifies immune-system activity and affects several biological pathways involved in cancer growth.
It can help the immune system recognize and attack abnormal cells, inhibit signals that support cancer-cell growth and interfere with blood-vessel formation that can support tumours. In certain bone-marrow disorders, it can also help improve the production of healthier blood cells.
9. Safety Advice
Pregnancy: Laviat/lenalidomide can cause severe birth defects or pregnancy loss. It must not be used during pregnancy. Strict pregnancy-prevention measures are required according to the applicable treatment program.
Breastfeeding: Breastfeeding should be avoided during treatment unless specifically directed otherwise by the treating physician.
Blood counts: Lenalidomide can reduce white blood cells, red blood cells and platelets. Regular blood monitoring is important.
Blood clots: Patients may have an increased risk of venous or arterial blood clots, particularly in certain multiple-myeloma treatment combinations. Seek urgent medical attention for symptoms such as unexplained chest pain, sudden breathlessness or swelling of a limb.
Kidney disease: Tell your doctor about kidney problems because dose adjustment may be required.
Driving: Dizziness, sleepiness or blurred vision may occur. Avoid driving or operating machinery if affected.
Alcohol: Discuss alcohol consumption with your healthcare professional because it may worsen dizziness or drowsiness.
Children: It is generally not recommended for children under 18 unless specifically directed by a specialist.
10. FAQs
Q1. What is Laviat 25 mg Capsule?
Laviat 25 mg is an oral capsule containing lenalidomide 25 mg, an immunomodulatory anti-cancer medicine.
Q2. What is Laviat 25 mg used for?
It is used for selected cases of multiple myeloma, myelodysplastic syndromes and certain lymphomas, depending on the treatment indication.
Q3. Can Laviat 25 mg be taken with food?
Yes, it may generally be taken with or without food. Follow the schedule provided by your doctor.
Q4. Can I crush or chew the capsule?
No. The capsule should be swallowed whole with water.
Q5. Does Laviat require regular blood tests?
Yes. Regular blood-count monitoring is important because lenalidomide can decrease blood-cell and platelet counts.
Q6. Can Laviat 25 mg be taken during pregnancy?
No. Lenalidomide can cause severe fetal harm and must not be used during pregnancy.
Q7. Can patients with kidney problems take Laviat?
It may be used in some patients, but kidney function can affect dosing. The treating physician should determine the appropriate dose.
Q8. Is Laviat 25 mg a prescription medicine?
Yes. It is a prescription oncology medicine and should be used under specialist supervision.
11. Substitutes for Laviat 25 mg
Because the active ingredient is lenalidomide 25 mg, products containing the same active ingredient and strength may be considered alternatives. Examples listed by Indian medicine references include:
- Lenangio 25 mg Capsule
- Lenalid 25 mg Capsule
- Lindoshil 25 mg Capsule
- Kabilen 25 mg Capsule
- Ledomed 25 mg Capsule
A substitute should not be selected solely by brand name or price. A doctor or pharmacist should confirm that the alternative has the same active ingredient, strength, formulation and appropriate indication.
12. SEO / B2B Keywords
For Phoenix Exim – Nagpur, India, useful informational/B2B keywords include:
- Laviat 25 mg Capsule exporter from India
- Laviat 25 mg Capsule supplier India
- Laviat 25 mg Lenalidomide exporter
- Laviat 25 mg pharmaceutical exporter Nagpur
- Lenalidomide 25 mg Capsule supplier India
- Lenalidomide 25 mg oncology medicine exporter
- Laviat 25 mg wholesale pharmaceutical supplier
- Laviat 25 mg medicine export from India
- Laviat 25 mg oncology medicine supplier
- Laviat 25 mg Capsule international pharmaceutical supplier
- Laviat 25 mg Capsule exporter to USA
- Laviat 25 mg Capsule exporter to UK
- Laviat 25 mg Capsule exporter to Australia
- Laviat 25 mg Capsule exporter to Canada
- Laviat 25 mg Capsule exporter to Singapore
- Laviat 25 mg Capsule exporter to South Korea
- Laviat 25 mg Capsule exporter to UAE
- Lenalidomide 25 mg supplier for international buyers
- Laviat 25 mg multiple myeloma medicine supplier
- Laviat 25 mg MDS medicine supplier
- Lenalidomide oncology medicine exporter from Nagpur
- Laviat 25 mg pharmaceutical trading company India
- Laviat 25 mg bulk medicine supplier
- Laviat 25 mg B2B pharmaceutical supplier
- Laviat 25 mg capsule wholesale exporter India
- Genuine Laviat 25 mg pharmaceutical supply
- Zydus Laviat 25 mg Capsule supplier India
- Lenalidomide 25 mg cancer medicine exporter India
- Laviat 25 mg international medicine supplier
- Phoenix Exim Laviat 25 mg exporter Nagpur India
Keywords







